Medicaid unwinding associated with less medication treatment for opioid use disorder

The end of pandemic-era enrollment enhancements for Medicaid was associated with a rise in the number of people ending medication treatment for opioid use disorder, as well as a decrease in the number of people beginning such treatment, according to a new RAND study.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup